Literature DB >> 33547381

Impaired inhibition of return during free-viewing behaviour in patients with schizophrenia.

Ken-Ichi Okada1,2,3, Kenichiro Miura4, Michiko Fujimoto4,5, Kentaro Morita6, Masatoshi Yoshida7,8,9, Hidenaga Yamamori4,5,10, Yuka Yasuda4,11,12, Masao Iwase5, Mikio Inagaki1,2, Takashi Shinozaki2,13, Ichiro Fujita1,2, Ryota Hashimoto14,15,16.   

Abstract

Schizophrenia affects various aspects of cognitive and behavioural functioning. Eye movement abnormalities are commonly observed in patients with schizophrenia (SZs). Here we examined whether such abnormalities reflect an anomaly in inhibition of return (IOR), the mechanism that inhibits orienting to previously fixated or attended locations. We analyzed spatiotemporal patterns of eye movement during free-viewing of visual images including natural scenes, geometrical patterns, and pseudorandom noise in SZs and healthy control participants (HCs). SZs made saccades to previously fixated locations more frequently than HCs. The time lapse from the preceding saccade was longer for return saccades than for forward saccades in both SZs and HCs, but the difference was smaller in SZs. SZs explored a smaller area than HCs. Generalized linear mixed-effect model analysis indicated that the frequent return saccades served to confine SZs' visual exploration to localized regions. The higher probability of return saccades in SZs was related to cognitive decline after disease onset but not to the dose of prescribed antipsychotics. We conclude that SZs exhibited attenuated IOR under free-viewing conditions, which led to restricted scene scanning. IOR attenuation will be a useful clue for detecting impairment in attention/orienting control and accompanying cognitive decline in schizophrenia.

Entities:  

Year:  2021        PMID: 33547381     DOI: 10.1038/s41598-021-82253-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  47 in total

1.  Stability of exploratory eye movements as a marker of schizophrenia--a WHO multi-center study. World Health Organization.

Authors:  T Kojima; E Matsushima; K Ohta; M Toru; Y H Han; Y C Shen; D Moussaoui; I David; K Sato; I Yamashita; N Kathmann; H Hippius; J X Thavundayil; S Lal; N P Vasavan Nair; S G Potkin; L Prilipko
Journal:  Schizophr Res       Date:  2001-12-01       Impact factor: 4.939

2.  The relationship between antisaccades, smooth pursuit, and executive dysfunction in first-episode schizophrenia.

Authors:  Samuel B Hutton; Vyv Huddy; Thomas R E Barnes; Trevor W Robbins; Trevor J Crawford; Christopher Kennard; Eileen M Joyce
Journal:  Biol Psychiatry       Date:  2004-10-15       Impact factor: 13.382

Review 3.  Eye tracking dysfunction in schizophrenia: characterization and pathophysiology.

Authors:  Deborah L Levy; Anne B Sereno; Diane C Gooding; Gilllian A O'Driscoll
Journal:  Curr Top Behav Neurosci       Date:  2010

Review 4.  Atypical scanpaths in schizophrenia: evidence of a trait- or state-dependent phenomenon?

Authors:  Sara A Beedie; Philip J Benson; David M St Clair
Journal:  J Psychiatry Neurosci       Date:  2011-05       Impact factor: 6.186

5.  Simple viewing tests can detect eye movement abnormalities that distinguish schizophrenia cases from controls with exceptional accuracy.

Authors:  Philip J Benson; Sara A Beedie; Elizabeth Shephard; Ina Giegling; Dan Rujescu; David St Clair
Journal:  Biol Psychiatry       Date:  2012-05-22       Impact factor: 13.382

6.  Limited eye movement patterns in chronic schizophrenic patients.

Authors:  T Kojima; S G Potkin; M Kharazmi; E Matsushima; J Herrera; Y Shimazono
Journal:  Psychiatry Res       Date:  1989-06       Impact factor: 3.222

7.  Eye movement as a biomarker of schizophrenia: Using an integrated eye movement score.

Authors:  Kentaro Morita; Kenichiro Miura; Michiko Fujimoto; Hidenaga Yamamori; Yuka Yasuda; Masao Iwase; Kiyoto Kasai; Ryota Hashimoto
Journal:  Psychiatry Clin Neurosci       Date:  2016-11-03       Impact factor: 5.188

8.  Antisaccade Deficits in Schizophrenia Can Be Driven by Attentional Relevance of the Stimuli.

Authors:  Sonia Bansal; John M Gaspar; Benjamin M Robinson; Carly J Leonard; Britta Hahn; Steven J Luck; James M Gold
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

Review 9.  Eye movement characteristics in schizophrenia: A recent update with clinical implications.

Authors:  Kentaro Morita; Kenichiro Miura; Kiyoto Kasai; Ryota Hashimoto
Journal:  Neuropsychopharmacol Rep       Date:  2019-11-27

10.  Small Saccades and Image Complexity during Free Viewing of Natural Images in Schizophrenia.

Authors:  Jose Ignacio Egaña; Christ Devia; Rocío Mayol; Javiera Parrini; Gricel Orellana; Aida Ruiz; Pedro E Maldonado
Journal:  Front Psychiatry       Date:  2013-05-20       Impact factor: 4.157

View more
  3 in total

1.  Eye tracking identifies biomarkers in α-synucleinopathies versus progressive supranuclear palsy.

Authors:  Annette Janzen; Douglas P Munoz; Mahboubeh Habibi; Wolfgang H Oertel; Brian J White; Donald C Brien; Brian C Coe; Heidi C Riek; Julia Perkins; Rachel Yep; Laurent Itti; Lars Timmermann; Christoph Best; Elisabeth Sittig
Journal:  J Neurol       Date:  2022-04-30       Impact factor: 6.682

Review 2.  Trends in big data analyses by multicenter collaborative translational research in psychiatry.

Authors:  Toshiaki Onitsuka; Yoji Hirano; Kiyotaka Nemoto; Naoki Hashimoto; Itaru Kushima; Daisuke Koshiyama; Michihiko Koeda; Tsutomu Takahashi; Yoshihiro Noda; Junya Matsumoto; Kenichiro Miura; Takanobu Nakazawa; Takatoshi Hikida; Kiyoto Kasai; Norio Ozaki; Ryota Hashimoto
Journal:  Psychiatry Clin Neurosci       Date:  2022-01       Impact factor: 12.145

3.  Neural Correlates of Variation in Personal Space and Social Functioning in Schizophrenia and Healthy Individuals.

Authors:  Sarah L Zapetis; Zahra Nasiriavanaki; Lauren Luther; Daphne J Holt
Journal:  Schizophr Bull       Date:  2022-09-01       Impact factor: 7.348

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.